Literature DB >> 21698555

Incidence of intussusception in early infancy: a capture-recapture estimate for Germany.

S Weiß1, A Streng, R von Kries, J Liese, S Wirth, A C Jenke.   

Abstract

BACKGROUND: Rotavirus (RV) vaccination with the first generation vaccine (Rotashield) has been associated with intussusception (IS). Reliable age specific baseline incidence data for children ≤6 months of age in particular is fundamental for further post marketing monitoring of potential effects of recently introduced new RV vaccines.
METHODS: IS incidence was estimated by a 2-source capture-recapture calculation (CRC) based on ESPED (German Paediatric Surveillance Unit) reports and on hospital discharge records for 2006 and 2007. ESPED as well as hospital records were validated according to the Brighton Collaboration's Group definition for definite IS. PATIENTS: Children that have been treated for IS in a hospital in one of two states of Germany (North-Rhine Westphalia and Bavaria).
RESULTS: The annual IS incidence for infants <1 year in Germany calculated with the CRC estimate in Germany was 61.7/100 000 (95% CI: 54.5-70.1). However, the incidence appeared to vary by month of age over a range of 19.2/100 000 cases (95% CI: 12.5-30.4) in the first 3 months of life to 98.5/100 000 cases (95% CI: 80.9-120.6) during the 6 (th) to 8 (th) month. The male to female ratio for infants was 1.7:1 (95%CI: 1.6-1.8).
CONCLUSION: The average incidence estimate for IS in infants (< 1 year) confirms previous estimates in Germany and Switzerland. However, age specific baseline incidence estimates for IS substantially vary during the first year of life. This has to be taken into account when analysing episodes of IS potentially associated with RV vaccination. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698555     DOI: 10.1055/s-0031-1279735

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  7 in total

1.  Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013.

Authors:  Na Liu; Catherine Yen; Tao Huang; Pengwei Cui; Jacqueline E Tate; Baoming Jiang; Umesh D Parashar; Zhao-Jun Duan
Journal:  Vaccine       Date:  2018-02-10       Impact factor: 3.641

2.  Rotavirus vaccination and short-term risk of adverse events in US infants.

Authors:  J Bradley Layton; Anne M Butler; Catherine A Panozzo; M Alan Brookhart
Journal:  Paediatr Perinat Epidemiol       Date:  2018-07-26       Impact factor: 3.980

3.  Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012.

Authors:  Kartini Gadroen; Jeanet M Kemmeren; Patricia Cj Bruijning-Verhagen; Sabine Mjm Straus; Daniel Weibel; Hester E de Melker; Miriam Cjm Sturkenboom
Journal:  Euro Surveill       Date:  2017-06-22

4.  Characteristics of intussusception among children in Korea: a nationwide epidemiological study.

Authors:  Soojin Jo; In Seok Lim; Soo Ahn Chae; Sin Weon Yun; Na Mi Lee; Su Yeong Kim; Dae Yong Yi
Journal:  BMC Pediatr       Date:  2019-06-28       Impact factor: 2.125

5.  Retrospective multicenter matched case-control study on the risk factors for intussusception in infants less than 1 year of age with a special focus on rotavirus vaccines - the German Intussusception Study.

Authors:  Doris Oberle; Marcus Hoffelner; Jutta Pavel; Dirk Mentzer; Immanuel Barth; Ursula Drechsel-Bäuerle; Brigitte Keller-Stanislawski
Journal:  Hum Vaccin Immunother       Date:  2020-04-09       Impact factor: 3.452

Review 6.  Childhood intussusception: a literature review.

Authors:  James Jiang; Baoming Jiang; Umesh Parashar; Trang Nguyen; Julie Bines; Manish M Patel
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

7.  Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study.

Authors:  Lamiya Samad; Mario Cortina-Borja; Haitham El Bashir; Alastair G Sutcliffe; Sean Marven; J Claire Cameron; Richard Lynn; Brent Taylor
Journal:  Vaccine       Date:  2013-07-17       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.